Monte Rosa Correlations
| GLUE Stock | USD 20.93 0.05 0.24% |
The current 90-days correlation between Monte Rosa Therapeutics and Day One Biopharmaceuticals is 0.18 (i.e., Average diversification). The correlation of Monte Rosa is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Monte Rosa Correlation With Market
Poor diversification
The correlation between Monte Rosa Therapeutics and DJI is 0.78 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Monte Stock
| 0.72 | DSGN | Design Therapeutics | PairCorr |
| 0.7 | ENGN | enGene Holdings Common | PairCorr |
| 0.75 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.89 | MRKR | Marker Therapeutics | PairCorr |
| 0.74 | AVE | Avecho Biotechnology | PairCorr |
| 0.84 | ANNX | Annexon | PairCorr |
| 0.62 | SLDB | Solid Biosciences LLC | PairCorr |
| 0.81 | AVCR | Avricore Health | PairCorr |
| 0.77 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.88 | TNGX | Tango Therapeutics | PairCorr |
| 0.65 | CADL | Candel Therapeutics | PairCorr |
Moving against Monte Stock
| 0.84 | GNLX | Genelux Common | PairCorr |
| 0.79 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.76 | LYRA | Lyra Therapeutics | PairCorr |
| 0.72 | ABP | Abpro Holdings | PairCorr |
| 0.69 | EDIT | Editas Medicine | PairCorr |
| 0.62 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.61 | KURA | Kura Oncology | PairCorr |
| 0.56 | EVGN | Evogene | PairCorr |
| 0.55 | QSI | QuantumSi | PairCorr |
| 0.41 | KRRO | Frequency Therapeutics | PairCorr |
| 0.33 | LRMR | Larimar Therapeutics | PairCorr |
| 0.76 | PRQR | ProQR Therapeutics | PairCorr |
| 0.76 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
| 0.66 | MREO | Mereo BioPharma Group | PairCorr |
| 0.58 | MBIO | Mustang Bio | PairCorr |
| 0.5 | PROK | ProKidney Corp | PairCorr |
| 0.4 | AURA | Aura Biosciences | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Monte Stock performing well and Monte Rosa Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Monte Rosa's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DAWN | 4.35 | 0.87 | 0.21 | 1.53 | 3.61 | 13.81 | 39.62 | |||
| ARVN | 3.06 | 0.60 | 0.16 | 2.94 | 3.12 | 5.91 | 28.90 | |||
| REPL | 2.58 | (0.47) | 0.00 | (0.78) | 0.00 | 5.56 | 14.00 | |||
| TBPH | 2.23 | 0.54 | 0.21 | 0.71 | 2.14 | 3.82 | 28.70 | |||
| AVBP | 2.96 | 0.32 | 0.10 | 0.47 | 3.00 | 6.71 | 18.12 | |||
| GERN | 2.81 | 0.27 | 0.10 | 0.16 | 2.84 | 7.76 | 16.99 | |||
| VIR | 3.34 | 0.41 | 0.11 | 0.27 | 3.40 | 8.08 | 20.46 | |||
| DNA | 3.35 | (0.39) | 0.00 | 1.98 | 0.00 | 8.16 | 28.96 | |||
| VALN | 2.20 | 0.03 | 0.00 | 0.57 | 2.35 | 4.83 | 15.59 | |||
| MGTX | 2.52 | (0.19) | 0.00 | (0.07) | 0.00 | 5.08 | 14.00 |
Monte Rosa Corporate Management
| Filip MD | Chief Officer | Profile | |
| Jennifer Champoux | VP Operations | Profile | |
| Sharon Townson | Chief Officer | Profile | |
| Edmund Dunn | Senior Controller | Profile | |
| John Castle | Chief Scientist | Profile | |
| Magnus DPHIL | Senior Development | Profile |